Comparison of Safety Profiles of EGFR Inhibitors

Opinion
Video

Key opinion leaders compare osimertinib's adverse event profile to other EGFR inhibitors, highlighting specific challenges and benefits observed in clinical practice

Video content above is prompted by the following:

  • In your experience, how does osimertinib’s adverse event profile compare to other EGFR inhibitors?
  • Are there specific challenges or benefits you’ve observed with osimertinib?
Recent Videos
Image of Pattie Jakel, MN, RN, AOCN, in front of a blue watercolor Oncology Nursing News backdrop
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Related Content